If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
1,773
Followers on Owler
Overview
Competitors
Acquisitions
Funding
News & Insights
Adaptimmune Funding History
Since Adaptimmune was founded in 2008, it has participated in 7 rounds of funding. In total Adaptimmune has raised $683.7M. Adaptimmune's last funding round was on May 2024 for a total of $100.0M.
Adaptimmune Funding Rounds
Unlock 4 more funding rounds →
ROUND
FUNDING DATE
AMOUNT
NUMBER OF INVESTORS
INVESTORS
Post-IPO Equity
May 2024
$100M
1
Galapagos NV
Post-IPO Debt
May 2024
$125M
1
Hercules Capital, Inc.
Post-IPO Equity
Sep 2018
$100M
1
Syncona Ltd
Post-IPO Equity
Mar 2017
$60.1M
__
IPO
May 2015
$191.3M
__
Adaptimmune Investors
Unlock 11 more investors →
INVESTOR
ROUND
FUNDING DATE
Galapagos NV
Post-IPO Equity
May 2024
Hercules Capital, Inc.
Post-IPO Debt
May 2024
Syncona Ltd
Post-IPO Equity
Sep 2018
New Enterprise Associates
Series A
Sep 2014
OrbiMed Advisors LLC
Series A
Sep 2014
Adaptimmune has 14 investors, including Galapagos NV, Hercules Capital, Inc. and Syncona Ltd. The latest investment occurred in May 2024.
